PharmaSGP Holding SE (PSG.DE)

28.5 €

+0.20 (+0.71%)
Symbol PSG.DE
Price 28.5 €
Beta -0.176
Volume Avg. 0.00M
Market Cap 342.000M
Shares () -
52 Week Range 21.0-29.6
1y Target Est -
DCF Unlevered PSG.DE DCF ->
DCF Levered PSG.DE LDCF ->
Operating Margin -
Debt / Equity -
P/E 30.32 Strong Buy
P/B -


Consensus EPS

Upgrades & Downgrades

Ms. Natalie Weigand
Drug Manufacturers—Specialty & Generic
Frankfurt Stock Exchange

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.